Stuart A. Arbuckle - 26 Feb 2025 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, COO
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
26 Feb 2025
Net transactions value
-$3,391,322
Form type
4
Filing time
28 Feb 2025, 16:31:03 UTC
Previous filing
26 Feb 2025
Next filing
15 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $3,391,322 -7,071 -10% $479.61 62,935 26 Feb 2025 Direct
holding VRTX Common Stock 140 26 Feb 2025 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.